Jérémie Waicenberg

Investment Manager at Merieux Equity Partners
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Lyon, Auvergne-Rhône-Alpes, France, FR
Languages
  • French Native or bilingual proficiency
  • English Full professional proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Thierry Picaud

Jérémie a été un très bon étudiant au sein de Sup'Biotech. Assez rapidement sûr de son projet professionnel, et maître de ses qualités personnelles, il a fait un parcours sans faute, liant de bons résultats scolaires avec de très belle réussite au sein de ses expériences de stage. Jérémie est quelqu'un de confiance, et qui sait prendre des décisions responsables. Thierry Picaud

Jerome Samson

Jérémie started as an Intern in our Investment team, and quickly jump to the pace and proved a valuable member of our team as an Analyst. During his time at Seventure, he contributed to several investment transactions, and has been highly appreciated both for his professional capabilities and his warm relationships within the team.

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • French Financial Market Authority (AMF) Certification
    Bärchen
    Jan, 2020
    - Nov, 2024

Experience

    • France
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Investment Manager
      • Apr 2019 - Present

      Mérieux Equity Partners is a global investment fund (from Seed to Growth Capital-Buy Out) specialized in the Life Sciences. Pertience Invest 2 representative: In charge of Seed and Early-stage Life Sciences investments. Mérieux Equity Partners is a global investment fund (from Seed to Growth Capital-Buy Out) specialized in the Life Sciences. Pertience Invest 2 representative: In charge of Seed and Early-stage Life Sciences investments.

    • France
    • Research Services
    • 1 - 100 Employee
    • Member of The Supervisory Board
      • Sep 2023 - Present

    • France
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Board Director
      • Dec 2021 - Present

    • France
    • Biotechnology Research
    • 1 - 100 Employee
    • Investor
      • Sep 2022 - Present

    • Board Director
      • Apr 2021 - Sep 2022

    • Spain
    • Biotechnology Research
    • 1 - 100 Employee
    • Board Director
      • Jun 2020 - Present

    • Food and Beverage Services
    • Co-Founder
      • Jan 2020 - Present

      Unique and artisanal producer of Mediterranean extra virgin olive oils, abterra invites you to take part in the branding of its exceptional products. Unique and artisanal producer of Mediterranean extra virgin olive oils, abterra invites you to take part in the branding of its exceptional products.

    • Estonia
    • Technology, Information and Internet
    • Board Director
      • Jan 2019 - Present

    • Advisor to the CEO
      • Sep 2018 - Mar 2019

      SCI-BRAIN is a scientific intelligence and analytics B2B SaaS platform that transforms information into actionable data using machine learning and data visualization. The current version of the toolbox helps to identify and map key opinion leaders in any scientific and technical field.

  • BioXchange
    • Paris Area, France
    • Chief Operating Officer
      • Sep 2015 - Sep 2017

      Social Network made by scientists, for scientists. This collaborative multi-function platform enhances communication and collaboration between PhDs, Engineers and Technicians. Social Network made by scientists, for scientists. This collaborative multi-function platform enhances communication and collaboration between PhDs, Engineers and Technicians.

    • France
    • Financial Services
    • 1 - 100 Employee
    • Life Sciences Manager
      • Jun 2013 - Jul 2015

      France Brevets is the first investment fund fully dedicated to patents in Europe. In charge of strategy, licensing activities and investments for Life Sciences. France Brevets is the first investment fund fully dedicated to patents in Europe. In charge of strategy, licensing activities and investments for Life Sciences.

    • France
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Analyst Life Sciences
      • Jan 2010 - Jun 2013

      Tiers 1 Life Sciences VC Fund in Europe Tiers 1 Life Sciences VC Fund in Europe

    • India
    • Information Services
    • 1 - 100 Employee
    • Corporate Business Development
      • Mar 2007 - Feb 2009

      Angels Santé: French Business Angels Network dedicated to Life Sciences Investments. SEPIES: Spin-off from the French National Institute of Health and Medical Research. Davkor: Medical Device start-up. Ipsen (Corporate Marketing Department): Pharmaceutical company. IMSTAR: Spin-off from the Biology Department of the French Atomic Energy Commission. Angels Santé: French Business Angels Network dedicated to Life Sciences Investments. SEPIES: Spin-off from the French National Institute of Health and Medical Research. Davkor: Medical Device start-up. Ipsen (Corporate Marketing Department): Pharmaceutical company. IMSTAR: Spin-off from the Biology Department of the French Atomic Energy Commission.

Education

  • Sup'Biotech, école de biotechnologies
    Master of Science (M.Sc.) – Master of Engineering (Dipl.-Eng.), Life Sciences
    2007 - 2009
  • Sup'Biotech, école de biotechnologies
    Bacherlor of Science (B.Sc.), Life Sciences
    2006 - 2007
  • Wine & Spirit Education Trust
    Level 3 – Award in Wines, Oenology
    2018 - 2018
  • Université Paris Diderot
    DEUG - 2-years University Diploma, Life Sciences
    2004 - 2006

Community

You need to have a working account to view this content. Click here to join now